Competitor Analysis: Wnt Pathway Inhibitors

Competitor Analysis: Wnt Pathway Inhibitors

Product description

Wnt proteins are secreted glycoproteins acting as short or long range signaling molecules. To trigger a cellular response and to activate intracellular signal transduction, they bind to receptors of the Frizzled family and several co-receptors such as lipoprotein receptor-related protein (LRP)-5/6, Ryk, or Ror2.

The present Competitive Intelligence report about Wnt Pathway Inhibitors provides a competitor evaluation in the field of small molecule-, antibody- and peptide-based inhibitors of Wnt and its receptors for the treatment of cancer as of September 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of small molecule, peptide and antibody inhibitors of the Wnt ligand or its receptors Frizzled and LRP5/6 in oncology. In addition, the report lists company-specific R&D pipelines of Wnt pathway inhibitors. Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.